Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
OBJECTIVE: To evaluate the efficacy and safety of tumor necrosis factor (TNF) inhibition with the p55 TNF receptor fusion protein (TNFr-Ig) for severe sight-threatening noninfectious posterior segment intraocular inflammation. METHODS: Seventeen patients with refractory noninfectious posterior segm...
Autors principals: | Murphy, C, Greiner, K, Plskova, J, Duncan, L, Frost, A, Isaacs, J, Rebello, P, Waldmann, H, Hale, G, Forrester, J, Dick, A |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2004
|
Ítems similars
-
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis
per: Sarjak M Shah, et al.
Publicat: (2025-01-01) -
Intraocular therapy in noninfectious uveitis
per: Rocco Luigi Modugno, et al.
Publicat: (2021-10-01) -
Emerging Therapies for Noninfectious Uveitis: What May Be Coming to the Clinics
per: Jose R. Maya, et al.
Publicat: (2014-01-01) -
Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis
per: Swetha Palla, et al.
Publicat: (2015-01-01) -
Campath-1H therapy in refractory ocular inflammatory disease.
per: Dick, A, et al.
Publicat: (2000)